The Spectrum of Anxiety Disorders in the Medically Ill
Objective: The purpose of this cross-sectional study was to assess the prevalence and characteristics of anxiety disorders in the medically ill.
Method: A sample of 1,660 medical patients was recruited from different medical settings in different periods from 1996 to 2007. All patients underwent detailed semistructured interviews with the Structured Clinical Interview for DSM-IV (SCID) and the Structured Interview for Diagnostic Criteria for Psychosomatic Research (DCPR).
Results: Generalized anxiety disorder was the most frequent anxiety disturbance (10.3%) and was associated with DCPR somatization syndromes, Type A behavior, and irritable mood. Panic disorder with agoraphobia and agoraphobia without history of panic disorder had almost identical prevalence (about 4.5%), but differed in some patterns of somatization. Agoraphobia without panic attacks was related to illness denial, persistent somatization, anniversary reactions, and demoralization. Much lower prevalence rates were reported for social phobia and obsessive-compulsive disorder.
Conclusions: The findings indicate that anxiety disorders are common in the setting of medical disease and are associated with several types of psychosomatic presentations. The links between agoraphobia without history of panic disorder and illness denial may provide an explanation for some discrepancies that have occurred in the literature as to the prevalence of agoraphobia in clinical samples compared to epidemiologic studies.
J Clin Psychiatry 2010;71(7):910–914
© Copyright 2010 Physicians Postgraduate Press, Inc.
Submitted: January 25, 2010; accepted March 16, 2010.
Online ahead of print: June 1, 2010 (doi:10.4088/JCP.10m06000blu).
Corresponding author: Giovanni A. Fava, MD, Department of Psychology, University of Bologna, Viale Berti Pichat 5, 40127, Bologna, Italy (email@example.com).
Anxiety disorders are strongly associated with chronic medical illness and physical disability.1 However, their specific features in the setting of medical disease have attracted limited attention compared to the literature that is available on mood disorders.2
The aim of this study was to provide information on the prevalence and characteristics of anxiety disturbances using a large database encompassing a variety of medical settings. The association of anxiety with psychosomatic syndromes and clusters, as defined by the Diagnostic Criteria for Psychosomatic Research (DCPR),2 was explored. The DCPR are a set of diagnostic criteria that were developed and validated by an international group of investigators to identify psychological constructs derived from psychosomatic research.2 They encompass abnormal illness behavior (disease phobia, thanatophobia, health anxiety, illness denial), somatization syndromes (persistent somatization, functional somatic symptoms secondary to a psychiatric disorder, conversion symptoms, anniversary reactions), demoralization, irritable mood, Type A behavior, and alexithymia.
Patients were recruited in different periods from 1996 to 2007 from different medical settings included in an ongoing multicenter project concerned with the psychosocial dimensions of medical patients.2 Although studies involved in the research project had different aims and sample sizes, they shared a common methodology in the assessment of psychopathology and psychosocial syndromes. Patients were recruited consecutively, with the intent of being representative of their respective patient populations:
1. Consecutive outpatients with functional gastrointestinal disorders (n = 190, 11.4% of the current total sample) from the Functional Gastrointestinal Disorders Outpatient Clinic of the Scientific Institute of Gastroenterology (Castellana Grotte, Italy).
2. Consecutive outpatients with heart diseases (n = 351, 21.1%) from 3 different sources: (1) 198 outpatients who underwent heart transplantation from the Heart Transplantation Unit of the Institute of Cardiology at S. Orsola Hospital of Bologna, Italy; (2) 61 consecutive patients with a recent (within 1 month) first myocardial infarction diagnosis from the Cardiac Rehabilitation Program of the Bellaria Hospital in Bologna, Italy; and (3) 92 consecutive outpatients with a recent (within 1 month) first myocardial infarction diagnosis from the Institute of Cardiology of University Hospital in Modena, Italy.
3. Consecutive outpatients with endocrine disorders (n = 162, 9.8%) from the Division of Endocrinology of the University of Padova Medical Center, Padova, Italy.
4. Consecutive outpatients who had received a diagnosis of cancer within the past 18 months (n = 104, 6.3%) from the S. Anna University Hospital in Ferrara, Italy.
5. Consecutive outpatients with skin disorders (n = 545, 32.8%) from the Dermopathic Institute of the Immaculate, Rome, Italy.
6. Consecutive inpatients referred for psychiatric consultation in 2 large university-based general hospitals (n = 208, 12.5%) from the University of Perugia and University of Foggia, Italy.
7. Selected outpatients recruited from a large primary clinic (n = 100, 6.0%) from Modena, Italy, representing the most frequent and the least frequent attendees.
The study was approved by an institutional review board, and written informed consent was obtained from all patients. The patients who were approached were 1,830; 170 (9.3%) declined to participate. The most common reason for refusal was lack of time. The total sample thus included 1,660 patients (746 men, 44.9%, and 914 women, 55.1%) with a mean age of 45 (SD = 15.02) years and a mean of 10.5 (SD = 3.98) years of education. There were no significant differences in terms of sociodemographic variables between the patients who accepted and those who refused.
All patients underwent 2 detailed semistructured interviews by clinical psychologists or psychiatrists with extensive experience in psychiatry, clinical psychology, and psychosomatic research. Anxiety disorders (panic disorder with and without agoraphobia, agoraphobia without history of panic disorder, specific phobias, social phobia, obsessive-compulsive disorder, generalized anxiety disorder, anxiety disorder not otherwise specified) were investigated with the Structured Clinical Interview for DSM-IV (SCID).3 The diagnosis of posttraumatic stress disorder was not included in the interview. Psychosomatic syndromes were diagnosed with the Structured Interview for DCPR.2 The interview for DCPR consists of 58 items scored in a yes-or-no response format evaluating the presence of 1 or more of 12 psychosomatic syndromes (alexithymia, Type A behavior, irritable mood, demoralization, disease phobia, thanatophobia, health anxiety, illness denial, functional somatic symptoms secondary to a psychiatric disorder, persistent somatization, conversion symptoms, and anniversary reaction). The interview has shown excellent interrater reliability, construct validity, and predictive validity for psychosocial functioning and treatment outcome.4 The χ2 test was used to assess differences in DCPR syndromes across groups.
Patients diagnosed with at least 1 anxiety disorder were 390 (23.5%); 117 (30.0%) had comorbidities with other Axis I disorders. Table 1 shows the frequency of each anxiety disorder in the different medical settings according to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria.
Click figure to enlarge
Generalized anxiety disorder (GAD) was the most frequent anxiety diagnosis (10.3%). Panic disorder with agoraphobia and agoraphobia without history of panic disorder had almost identical prevalence (4.6% and 4.5%, respectively). Less frequent were specific phobias (1.8%), panic disorder without agoraphobia (1.5%), obsessive-compulsive disorder (1.6%), social phobia (0.7%), and anxiety disorder not otherwise specified (0.2%). For assessing the psychosomatic correlates of anxiety disturbances, the prevalence of DCPR diagnoses in each anxiety disorder was determined (Table 2).
Click figure to enlarge
Patients with panic disorder with agoraphobia and agoraphobia without panic attacks shared some clinically relevant characteristics of abnormal illness behavior (significant associations with the DCPR syndromes of health anxiety and disease phobia), patterns of somatization (significant associations with functional somatic symptoms secondary to a psychiatric disorder), and irritability. However, patients with agoraphobia without panic showed further unique, distinct associations with demoralization, persistent somatization, anniversary reaction, and, particularly, illness denial.
Patients with generalized anxiety disorder had higher prevalence of health anxiety, functional somatic symptoms secondary to a psychiatric disorder, persistent somatization, anniversary reaction, Type A behavior, and irritable mood. Obsessive-compulsive disorder was significantly related to disease phobia, thanatophobia, Type A behavior, irritable mood, and demoralization.
Social phobia did not display any significant associations with DCPR syndromes, whereas specific phobias had higher prevalence of demoralization.
The findings of this study have considerable limitations. First, the population sample was heterogeneous, since it consisted of patients recruited from very different settings (inpatient versus outpatient facilities; tertiary care versus primary care versus consultation activities). Second, in many cases, patients were recruited from consecutive and unselected series; in other cases, they reflected a request from consultation or specific investigation purposes (eg, frequent attenders). Finally, establishing psychiatric diagnoses in the setting of medical disease is a difficult task, which many times is hindered by medical comorbidity and drugs.5,6 Nonetheless, this investigation has yielded important clinical implications, and the heterogeneity of the population sample could also be one of the strengths of the study, in the sense that the spectrum of anxiety disturbances was explored in the most diverse clinical situations.
In terms of diagnostic distribution of the anxiety spectrum, the most striking finding was the roughly equivalent prevalence of DSM-IV panic disorder with agoraphobia (4.6%) and agoraphobia without history of panic disorder (4.5%). There is considerable controversy on the prevalence and validity of this latter diagnosis in clinical settings.7–9 Its well-established prevalence in epidemiologic samples, as confirmed by careful recent investigations,10–12 has been explained on the basis of a higher likelihood of lay interviewers to diagnose it compared to clinical investigators.7 Our study, which employed experienced clinical interviewers (MD or PhD with at least 3 years of clinical experience and specific training for recognizing the subclinical manifestations of panic), provides evidence to the contrary in the medically ill and also some explanations for the occurrence of this discrepancy in clinical studies.
There is extensive literature, reviewed in detail elsewhere,13 on the fact that patients with panic disorder and agoraphobia display significantly more hypochondriacal fears and beliefs compared to healthy subjects. Indeed, we also found significant associations with the DCPR syndromes of health anxiety and disease phobia in our sample. However, patients with agoraphobia without history of panic attacks displayed a highly significant association with illness denial. Persistent denial of having a medical disorder and needing treatment (eg, lack of compliance, delay in seeking medical attention) frequently occurs in the medical setting.2,14,15 If panic attacks have not taken place, agoraphobic fears tend to be “very refined and subtle, appear natural to the individual (and even part of his or her character) and are often highly rationalized.”16(p560) It is only when a review of the patient’s behavior is performed and exposure to phobic avoidances is encouraged17 that “these patients become aware that their avoidances are not natural or inevitable.”16(p560) Not surprisingly, there were no diagnoses of agoraphobia without panic attacks in the setting of consultation-liaison psychiatry, whereas panic disorder accounted for about 7% of diagnoses. Further, in our sample, agoraphobia without panic was also significantly related to the poor insight into the role of psychological states in the production of somatic symptoms that occurs in DCPR persistent somatization (a clustering of functional symptoms involving different organ systems) and anniversary reactions (a special form of conversion related to anniversaries, such as when the patient reaches the age of a parent who died).2 Our findings thus suggest that agoraphobic fears, unlike panic attacks, do not tend to lead individuals to seek medical attention, even though they are associated with psychosomatic manifestations that impair quality of life.6,15 The identification of these fears requires careful expert interviewing, well beyond the checklist use of diagnostic instruments,8 to overcome the denial that underlies agoraphobia and other distress manifestations.
Indeed, the DSM-V Task Force core proposal for agoraphobia provides a better specification of the cluster of agoraphobic situations, such as being outside the home alone; using public transportation; being in open spaces; being in shops, theaters, or cinemas; standing in line; or being in a crowd.9 A key clinical clue is the fact that mobility often requires the presence of a companion and/or should involve very familiar routes and places.8
Engel18 outlined how feelings of helplessness and giving up may be associated with anniversaries. Indeed, demoralization, the consciousness of being unable to cope with a pressing problem or having failed to meet one’s own expectations or those of others,2,19 was found to characterize agoraphobia without history of panic disorder.
The findings thus support the view that agoraphobia should be conceptualized as an independent disease and not as simply a subordinate, residual form of panic disorder.9
The other diagnostic findings deserve brief comment. The overall prevalence rates of anxiety disorders that were found in our medical population exceeded those of epidemiologic studies performed in Italian general populations by clinicians.20,21
This particularly applies to panic disorder, agoraphobia without history of panic attacks, and generalized anxiety, whereas the other anxiety disturbances were within the expected ranges. Generalized anxiety disorder was the most frequent diagnosis (about 10% of cases), which is in line with the reported literature.22 There were significant associations with somatization, abnormal illness behavior, Type A behavior, and irritable mood. The prevalence of social phobia (0.7%) in medical patients was lower than expected22: cases were limited to cardiology and dermatology.
While in specific settings (patients for whom consultation-liaison psychiatry was requested or frequent attenders of family practice) there might be an effect related to the type of population sample, it is difficult to explain the lack of cases in gastroenterology, endocrinology, and oncology. However, a recent survey of anxiety disorders in psychosomatic inpatients23 also suggested that social phobia was comparatively rare. The low number of subjects with social anxiety in our investigation might explain the lack of significant correlations with psychosomatic variables.
Obsessive-compulsive disorder (1.6%) was related to dimensions of abnormal illness behavior, such as disease phobia and thanatophobia, as previously reported in psychiatric settings.13 Type A behavior, irritable mood, and demoralization were also associated with obsessive-compulsive disorder.
The results of the present investigation thus indicate that anxiety disorders have important clinical implications in the setting of medical disease, as previously reported.1 In view of the methodology that was used for assessing patients’ psychosomatic manifestations based on DCPR,2 the findings offer new insights into the characteristics of these manifestations. In particular, the results should alert physicians who are confronted with illness denial to look for symptoms related to agoraphobic avoidance. The clinical usefulness of incorporating DCPR criteria in the psychological assessment of the medically ill5,6,24 is also supported.
In our sample, agoraphobia without history of panic disorder was found to be as common as panic disorder with agoraphobia. This provides full justification for retaining the diagnosis of agoraphobia in future diagnostic developments.8,9
Author affiliations: Laboratory of Psychosomatics and Clinimetrics, Department of Psychology, University of Bologna, Bologna, Italy (Drs Fava, Rafanelli, Mangelli, and Grandi); the Psychosomatic Unit, IRCCS De Bellis Hospital, Castellana Grotte, Italy (Dr Porcelli); and the Department of Psychiatry, State University of New York, Buffalo (Dr Fava).
Potential conflicts of interest: None reported.
Funding/support: The study was supported in part by a grant from the Compagnia di San Paolo (a research foundation based in Torino, Italy) to Dr Rafanelli.
Acknowledgment: We are indebted to Antonello Bellomo, MD (Section of Psychiatry and Clinical Psychology, Department of Medical Sciences, University of Foggia, Foggia, Italy); Silvia Ferrari, MD (Department of Neuroscience – TCR, University of Modena and Reggio Emilia, Modena, Italy); Luigi Grassi, MD (Department of Medical Sciences of Communication and Behavior, Section of Psychiatry, University of Ferrara, Italy); Angelo Picardi, MD (Italian National Institute of Health Center of Epidemiology, Surveillance and Health Promotion, Mental Health Unit, Rome, Italy); Roberto Quartesan, MD (Section of Psychiatry, Clinical Psychology and Psychiatric Rehabilitation, Department of Clinical and Experimental Medicine, University of Perugia, Perugia, Italy); Marco Rigatelli, MD (Department of Neuroscience – TCR, University of Modena and Reggio Emilia, Modena, Italy); and Nicoletta Sonino, MD (Department of Statistical Sciences, University of Padova, and Department of Mental Health, Padova, Italy), for the use of collaborative data. None of the above mentioned acknowledged individuals has financial disclosure and conflicts of interest to report.
1. Roy-Byrne PP, Davidson KW, Kessler RC, et al. Anxiety disorders and comorbid medical illness. Gen Hosp Psychiatry. 2008;30(3):208–225. PubMed doi:10.1016/j.genhosppsych.2007.12.006
2. Porcelli P, Sonino N, eds. Psychological Factors Affecting Medical Conditions. Basel, Switzerland: Karger; 2007.
3. First MB, Spitzer RL, Gibbon M, et al. SCID-I–Structured Clinical Interview for DSM-IV Axis I Disorders (Italian version by Mazzi F, Morosini P, De Girolamo G, Lussetti M, Guaraldi GP). Firenze, Italy: Organizzazioni Speciali; 2000.
4. Sirri L, Fabbri S, Fava GA, et al. New strategies in the assessment of psychological factors affecting medical conditions. J Pers Assess. 2007;89(3):216–228.
5. Fava GA, Sonino N. Psychosomatic assessment. Psychother Psychosom. 2009;78(6):333–341. PubMed doi:10.1159/000235736
6. Wise TN. Diagnostic criteria for psychosomatic research are necessary for DSM V. Psychother Psychosom. 2009;78(6):330–332. PubMed doi:10.1159/000235735
7. Somers JM, Goldner EM, Waraich P, et al. Prevalence and incidence studies of anxiety disorders: a systematic review of the literature. Can J Psychiatry. 2006;51(2):100–113. PubMed
8. Fava GA, Rafanelli C, Tossani E, et al. Agoraphobia is a disease: a tribute to Sir Martin Roth. Psychother Psychosom. 2008;77(3):133–138. PubMed doi:10.1159/000116606
9. Wittchen HU, Gloster AT, Beesdo-Baum K, et al. Agoraphobia: a review of the diagnostic classificatory position and criteria. Depress Anxiety. 2010;27(2):113–133. PubMed doi:10.1002/da.20646
10. Bienvenu OJ, Onyike CU, Stein MB, et al. Agoraphobia in adults: incidence and longitudinal relationship with panic. Br J Psychiatry. 2006;188(5):432–438. PubMed doi:10.1192/bjp.bp.105.010827
11. Wittchen HU, Nocon A, Beesdo K, et al. Agoraphobia and panic: prospective-longitudinal relations suggest a rethinking of diagnostic concepts. Psychother Psychosom. 2008;77(3):147–157. PubMed doi:10.1159/000116608
12. Faravelli C, Cosci F, Rotella F, et al. Agoraphobia between panic and phobias: clinical epidemiology from the Sesto Fiorentino Study. Compr Psychiatry. 2008;49(3):283–287. PubMed doi:10.1016/j.comppsych.2007.12.001
13. Fava GA, Mangelli L. Hypochondriasis and anxiety disorders. In: Starcevic V, Lipsitt DR, eds. Hypochondriasis. New York, NY: Oxford University Press; 2001:89–102.
14. Fava GA, Wise TN. Issues for DSM-V: psychological factors affecting either identified or feared medical conditions: a solution for somatoform disorders. Am J Psychiatry. 2007;164(7):1002–1003. PubMed doi:10.1176/appi.ajp.164.7.1002
15. Porcelli P, Bellomo A, Quartesan R, et al. Psychosocial functioning in consultation-liaison psychiatry patients: influence of psychosomatic syndromes, psychopathology and somatization. Psychother Psychosom. 2009;78(6):352–358. PubMed doi:10.1159/000235739
16. Furlong FW. Antecedents of “spontaneous” panic attacks. Am J Psychiatry. 1989;146(4):560. PubMed
17. Fava GA, Grandi S, Canestrari R. Prodromal symptoms in panic disorder with agoraphobia. Am J Psychiatry. 1988;145(12):1564–1567. PubMed
18. Engel GL. The death of a twin: mourning and anniversary reactions: fragments of 10 years of self-analysis. Int J Psychoanal. 1975;56(1):23–40. PubMed
19. Cockram CA, Doros G, de Figueiredo JM. Diagnosis and measurement of subjective incompetence: the clinical hallmark of demoralization. Psychother Psychosom. 2009;78(6):342–345. PubMed doi:10.1159/000235737
20. Faravelli C, Abrardi L, Bartolozzi D, et al. The Sesto Fiorentino study: point and one-year prevalences of psychiatric disorders in an Italian community sample using clinical interviewers. Psychother Psychosom. 2004;73(4):226–234. PubMed doi:10.1159/000077741
21. Gigantesco A, Palumbo G, Mirabella F, et al. Prevalence of psychiatric disorders in an Italian town: low prevalence confirmed with two different interviews. Psychother Psychosom. 2006;75(3):170–176. PubMed doi:10.1159/000091774
22. Goldberg RJ, Posner DA. Anxiety in the medically ill. In: Stoudemire A, Fogel BS, Greenberg BD, eds. Psychiatric Care of the Medical Patient. 2nd ed. New York, NY: Oxford University Press; 2000:165–180.
23. Beutel ME, Bleichner F, von Heymann F, et al. Anxiety disorders and comorbidity in psychosomatic inpatients. Psychother Psychosom. 2010;79(1):58. PubMed doi:10.1159/000259419
24. Fava GA, Sonino N. Psychosomatic medicine: a name to keep. Psychother Psychosom. 2010;79(1):1–3. PubMed doi:10.1159/000254899